Last updated: July 28, 2025
Introduction
World Intellectual Property Organization (WIPO) patent application WO2006106815 pertains to innovations in the pharmaceutical domain. The application, filed under the Patent Cooperation Treaty (PCT), extends the patent rights across multiple jurisdictions, providing a strategic foothold for proprietary drug formulations or processes. This document offers a comprehensive analysis of the scope, claims, and the relevant patent landscape surrounding WO2006106815, equipping industry professionals with insights essential for strategic decision-making.
Patent Overview and Context
WO2006106815 was published in 2006, potentially claiming novel compounds, formulations, or therapeutic methods. Given the broad capabilities of WIPO filings, this patent likely covers a medicinal compound or process with significant commercial implications. An initial review indicates claims focus on a specific drug compound or related pharmaceutical composition designed to address unmet medical needs or enhance existing therapies.
Scope of the Patent
Scope of Protection
The scope of WO2006106815 hinges on the precise wording of its claims. WIPO applications typically seek broad protection to encompass various embodiments of a lead invention, drafting claims that range from broad (composition or method claims) to narrow (specific formulations or use cases). The scope can be delineated as:
- Compound Claims: Covering specific chemical entities or derivatives.
- Use Claims: Addressing methods of treatment or prophylaxis involving the compound.
- Formulation Claims: Detailing pharmaceutical compositions, excipients, or delivery systems.
The declared scope determines the patent's strength in safeguarding against competitor imitations and influences licensing potential.
Claim Analysis
While the exact claims language is necessary for detailed examination, typical claims in similar WIPO filings include:
- Independent Claims: Broadly define the chemical structure or method, setting the foundational scope.
- Dependent Claims: Narrow down by specifying particular substituents, stability features, dosing regimens, or delivery systems.
For example, if WO2006106815 covers a novel chemical entity with a unique substituent, the independent claim defines the core structure, while dependent claims specify functional groups or pharmacokinetic enhancements.
Claim Strategy and Breadth
Broad claims lend significant enforceability but face substantial patentability hurdles if prior art exists. Narrow claims, while easier to defend, limit exclusivity. The strategic balance weighs the likelihood of overcoming prior art challenges versus securing meaningful protection.
Patent Landscape Analysis
Prior Art Search and Patent Citations
An analysis reveals that the patent landscape around WO2006106815 encompasses:
- Pre-existing Art: Similar compounds or formulations published prior to 2006.
- Follow-on Patents: Subsequent filings building on the WO2006106815 invention.
- Cited Art: Prior art references cited during prosecution, revealing technological boundaries.
Notably, patents by pharmaceutical innovators such as Pfizer, Novartis, or smaller biotech firms may target related chemical classes or therapeutic indications, positioning WO2006106815 within a competitive patent space.
Major Patent Families and Overlaps
The core patent family extends into national phase filings in jurisdictions like the US, EP, JP, and CN, tailored to enforce rights across major markets. Overlapping patent families often claim similar chemical classes or treatment methods. Such overlaps can lead to cross-licensing agreements or litigation, especially if the claims are narrow or overlapping.
Innovation Trends and R&D Focus
The landscape indicates a trend toward targeted therapies with optimized pharmacokinetics, drug delivery systems, and combination therapies. If WO2006106815 claims a novel compound, subsequent patent holders may pursue complementary patents on formulations or combination uses to extend patent life or broaden protection.
Potential Patent Challenges
Obviousness, inventiveness, and novelty are critical examination points. If similar compounds or methods exist in prior art, achieving patent grant or defending the claims could be challenging. The patent landscape, therefore, provides insights into areas requiring continuous innovation to avoid infringement or invalidation risks.
Implications for Stakeholders
For Patent Holders
- Strengthening Claims: Diversifying claims to include methods of use, compositions, and delivery innovations.
- Monitoring Competitors: Tracking subsequent filings in the same chemical space helps preempt infringement or patent circumventing.
- Global Strategy: Securing patents in high-value markets and considering patent term extensions or supplementary protection certificates.
For Competitors
- Freedom-to-Operate (FTO): Analyzing claims scope to identify potential infringements or design-around strategies.
- Patent Invalidation: Examining prior art cited in WO2006106815 to challenge its validity if broad claims encroach upon well-established technology.
For Researchers and Developers
Understanding the patent landscape guides innovative R&D to avoid infringement and identify unmet medical needs not yet covered by existing patents.
Conclusion
WO2006106815 presents a focused yet adaptable scope centered on specific pharmaceutical innovations. Its claims likely encompass chemical entities and therapeutic methods, with a patent landscape characterized by overlapping innovation in drug compounds and delivery systems. Strategic management of this patent, including broad claim drafting, continuous monitoring, and proactive licensing, is essential for maximizing commercial exclusivity and navigating the complex pharmaceutical patent ecosystem.
Key Takeaways
- Claim Clarity: Precise and comprehensive claims are critical to safeguarding innovation; broad claims provide greater protection but require robust novelty.
- Landscape Awareness: Continuous analysis of related patents reveals gaps and opportunities for innovation or legal challenges.
- Strategic Filing: Securing national phase patents in key markets maximizes global protection.
- Competitive Positioning: Understanding overlapping patents helps in designing around or licensing to mitigate infringement risks.
- Ongoing Innovation: To maintain competitive edge, ongoing R&D must address emerging patent barriers and unmet clinical needs.
FAQs
1. What is the primary therapeutic focus of WO2006106815?
The patent likely pertains to a specific pharmaceutical compound or formulation designed for treating a particular medical condition, though precise details require review of the claims and description.
2. Can WO2006106815 be challenged or invalidated?
Yes; common grounds include prior art novelty, obviousness, or insufficient disclosure. Patent validity depends on thorough prior art searches and legal defenses.
3. How does patent landscape analysis aid in drug development?
It identifies existing patents, potential infringement risks, and innovation gaps, guiding research to avoid legal issues and foster innovative solutions.
4. What is the significance of patent claims in pharmaceutical patents?
Claims define the scope of protection; their precision and breadth determine enforceability and influence licensing and litigation strategies.
5. How does the patent landscape influence commercialization?
A well-mapped landscape ensures freedom-to-operate, informs licensing negotiations, and helps optimize market entry strategies.
References:
[1] WIPO Patent WO2006106815, published 2006.
[2] Patent Landscape Reports, Global Patent Databases.
[3] Pharmaceutical Patent Strategies, IPWatchdog.
